Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis

類似資料

• Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer
  著者:: Puhan, Milo A., 等
  出版事項: (2015)
• Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit–harm balance modeling study
  著者:: Yebyo, Henock G., 等
  出版事項: (2019)
• Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
  著者:: Yebyo, Henock G., 等
  出版事項: (2018)
• Quantitative benefit–harm assessment for setting research priorities: the example of roflumilast for patients with COPD
  著者:: Puhan, Milo A., 等
  出版事項: (2015)
• Aspirin for the prevention of cardiovascular disease: calculating benefit and harm in the individual patient
  著者:: Loke, Yoon Kong, 等
  出版事項: (2003)